Anti-inflammatory effect of visnagin in lipopolysaccharide-stimulated BV-2 microglial cells

Archives of Pharmacal Research

Volumn 33, Issue 11, 2010, Pages 1843-1850

  Lee, Jin Koo ^a   Jung, Jun Sub ^a   Park, Sang Hee ^a   Park, Soo Hyun ^a   Sim, Yun Beom ^a   Kim, Seon Mi ^a   Ha, Tal Soo ^b   Suh, Hong Won ^a  

^a Hallym University   (South Korea)

^b Daegu University   (South Korea)

Author keywords

Anti inflammation; AP 1; Inducible nitric oxide synthase; Microglial cells; NF B; Visnagin

Indexed keywords

GAMMA INTERFERON; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 1BETA; INTERLEUKIN 6; LIPOPOLYSACCHARIDE; MESSENGER RNA; MONOCYTE CHEMOTACTIC PROTEIN 1; NITRIC OXIDE; TRANSCRIPTION FACTOR AP 1; TUMOR NECROSIS FACTOR ALPHA; VISNAGIN;

ANTIINFLAMMATORY ACTIVITY; ARTICLE; CELL STRAIN; CELL STRAIN BV2; CONCENTRATION RESPONSE; CYTOKINE RELEASE; DRUG EFFECT; INTERFERON PRODUCTION; MICROGLIA; PROTEIN EXPRESSION;

AMMI; ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CELL LINE; CYTOKINES; FRUIT; INFLAMMATION; KHELLIN; LIPOPOLYSACCHARIDES; MICE; MICROGLIA; NF-KAPPA B; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE II; PHYTOTHERAPY; TRANSCRIPTION FACTOR AP-1;

EID: 78751489115     PISSN: 02536269     EISSN: 19763786     Source Type: Journal    
DOI: 10.1007/s12272-010-1117-1     Document Type: Article

References (33)

1. Aquilano, K, Baldelli, S., Rotilio, G., and Ciriolo, M. R., Role of nitric oxide synthases in Parkinson's disease: a review on the antioxidant and anti-inflammatory activity of polyphenols. Neurochem. Res., 33, 2416-2426 (2008).
2. Bae, E. A., Kim, E. J., Park, J. S., Kim, H. S., Ryu, J. H., and Kim, D. H., Ginsenosides Rg3 and Rh2 inhibit the activa-tion of AP-1 and protein kinase A pathway in lipopolysac-charide/interferon-gamma-stimulated BV-2 microglial cells. Planta Med., 72, 627-633 (2006).
3. Candelario-Jalil, E., De Oliveira, A. C, Graf, S., Bhatia, H. S., Hull, M., Munoz, E., and Fiebich, B. L., Resveratrol potently reduces prostaglandin E2 production and free radical formation in lipopolysaccharide-activated primary rat microglia. J. Neuroinflammation, 4, 25 (2007).
4. Chen, J. C, Ho, F. M., Pei-Dawn Lee, C, Chen, C. P., Jeng, K. C, Hsu, H. B, Lee, S. T, Wen Tung, W, and Lin, W. W., Inhibition of iNOS gene expression by quercetin is mediated by the inhibition of IkappaB kinase, nuclear factor-kappa B and STAT1, and depends on heme oxygenase-1 induction in mouse BV-2 microglia. Eur. J. Pharmacol., 521, 9-20 (2005).
5. Chu, S. C, Marks-Konczalik, J, Wu, H. P, Banks, T. C, and Moss, J., Analysis of the cytokine-stimulated human in-ducible nitric oxide synthase (iNOS) gene: characteriza-tion of differences between human and mouse iNOS pro-moters. Biochem. Biophys. Res. Commun., 248, 871-878 (1998).
6. De Simone, R., Levi, G., and Aloisi, F., Interferon gamma gene expression in rat central nervous system glial cells. Cytokine, 10, 418-422 (1998).
7. Duarte, J., Perez-Vizcaino, F., Torres, A. I., Zarzuelo, A., Jimenez, J., and Tamargo, J., Vasodilator effects of visnagin in isolated rat vascular smooth muscle. Eur. J. Pharmacol., 286, 115-122 (1995).
8. Duarte, J., Torres, A. I., and Zarzuelo, A., Cardiovascular effects of visnagin on rats. Planta Med., 66, 35-39 (2000).
9. Faggioli, L., Costanzo, C, Donadelli, M., and Palmieri, M., Activation of the Interleukin-6 promoter by a dominant negative mutant of c-Jun. Biochim. Biophys. Acta, 1692, 17-24 (2004).
10. Graeber, M. B. and Streit, W. J., Microglia: biology and pathology. Acta Neuropathol., 119, 89-105 (2010).
11. Jang, S., Kelley, K. W., and Johnson, R. W., Luteolin reduces IL-6 production in microglia by inhibiting JNK phos-phorylation and activation of AP-1. Proc. Natl. Acad. Sci. U.S.A., 105, 7534-7539 (2008).
12. Jung, J. S., Yan, J. J., and Song, D. K., Protective effect of decursinol on mouse models of sepsis: enhancement of interleukin-10. Korean J. Physiol. Pharmacol., 12, 79-81 (2008).
13. Kao, T. K., Ou, Y. C, Raung, S. L, Lai, C. Y, Liao, S. L, and Chen, C. J., Inhibition of nitric oxide production by quer-cetin in endotoxin/cytokine- stimulated microglia. Life Sci., 86, 315-321 (2010).
14. Kaul, B. and Staba, E. J., Visnagin: biosynthesis and iso-lation from Ammi visnagi suspension cultures. Science, 150, 1731-1732 (1965).
15. Kawanokuchi, J., Mizuno, T., Takeuchi, H., Kato, H., Wang, J., Mitsuma, N., and Suzumura, A., Production of inter-feron-gamma by microglia. Mult. Scler., 12, 558-564 (2006).
16. Lee, C. J, Lee, S. S, Chen, S. C, Ho, F. M, and Lin, W. W., Oregonin inhibits lipopolysaccharide-induced iNOS gene transcription and upregulates HO-1 expression in macro-phages and microglia. Br. J. Pharmacol., 146, 378-388 (2005).
17. Lu, D. Y., Tang, C. H., Chen, Y. H., and Wei, I. H., Berberine suppresses neuroinflammatory responses through AMP-activated protein kinase activation in BV-2 microglia. J. Cell. Biochem., 110, 697-705 (2010).
18. Park, S. H, Kang, J. S, Yoon, Y. D, Lee, K, Kim, K. J, Lee, K. H, Lee, C. W, Moon, E. Y, Han, S. B, Kim, B. H, Kim, H. M., and Park, S. K., Glabridin inhibits lipopolysaccha-ride-induced activation of a microglial cell line, BV-2, by blocking NF-kappaB and AP-1. Phytother. Res., 24 Suppl 1, S29-S34 (2010).
19. Perez, R. L., Ritzenthaler, J. D., and Roman, J., Transcrip-tional regulation of the interleukin-1beta promoter via fibrinogen engagement of the CD18 integrin receptor. Am. J. Respir. Cell Mol. Biol., 20, 1059-1066 (1999).
20. Rauwald, H. W., Brehm, O., and Odenthal, K P., The involvement of a Ca2+ channel blocking mode of action in the pharmacology of Ammi visnaga fruits. Planta Med., 60, 101-105 (1994).
21. Ray, B. and Lahiri, D. K., Neuroinflammation in Alzheimer's disease: different molecular targets and potential thera-peutic agents including curcumin. Curr. Opin. Pharmacol., 9, 434-444 (2009).
22. Saraiva, M. and O'garra, A., The regulation of IL-10 produc-tion by immune cells. Nat Rev. Immunol., 10, 170-181 (2010).
23. Saud, K., Herrera-Molina, R., and Von Bernhardi, R., Pro-and anti-inflammatory cytokines regulate the ERK path-way: implication of the timing for the activation of micro-glial cells. Neurotox. Res., 8, 277-287 (2005).
24. Strle, K, Zhou, J. H., Shen, W. H., Broussard, S. R., Johnson, R. W., Freund, G. G., Dantzer, R., and Kelley, K W., Interleukin-10 in the brain. Crit Rev. Immunol., 21, 427-449 (2001).
25. Thompson, W. L., Karpus, W. J., and Van Eldik, L. J., MCP-1-deficient mice show reduced neuroinflammatory responses and increased peripheral inflammatory responses to peripheral endotoxin insult. J. Neuroinflammation, 5, 35 (2008).
26. Tuttolomondo, A., Di Raimondo, D., Di Sciacca, R., Pinto, A., and Licata, G., Inflammatory cytokines in acute ischemic stroke. Curr. Pharm. Des., 14, 3574-3589 (2008).
27. Tzeng, S. F., Hsiao, H. Y., and Mak, O. T., Prostaglandins and cyclooxygenases in glial cells during brain inflamma-tion. Curr. Drug Targets Inflamm. Allergy, 4, 335-340 (2005).
28. Ubeda, A., Tejerina, T., Tamargo, J., and Villar, A., Effects of khellin on contractile responses and 45Ca2+ movements in rat isolated aorta. J. Pharm. Pharmacol., 43, 46-48 (1991).
29. Udalova, I. A. and Kwiatkowski, D., Interaction of AP-1 with a cluster of NF-kappa B binding elements in the human TNF promoter region. Biochem. Biophys. Res. Commun., 289, 25-33 (2001).
30. Vanachayangkul, P., Byer, K., Khan, S., and Butterweck, V, An aqueous extract of Ammi visnaga fruits and its con-stituents khellin and visnagin prevent cell damage caused by oxalate in renal epithelial cells. Phytomedicine, 17, 653-658 (2010).
31. Wang, J., Barke, R. A., Charboneau, R., Loh, H. H., and Roy, S., Morphine negatively regulates interferon-gamma pro-moter activity in activated murine T cells through two distinct cyclic AMP-dependent pathways. J. Biol. Chem., 278, 37622-37631 (2003).
32. Yang, X, Du, L, Tang, X, Jung, S. Y, Zheng, B., Soh, B. Y., Kim, S. Y., Gu, Q., and Park, H., Brevicompanine E reduces lipopolysaccharide-induced production of proinflamma-tory cytokines and enzymes in microglia by inhibiting activation of activator protein-1 and nuclear factor-kappaB. J. Neuroimmunol., 216, 32-38 (2009).
33. Zhang, F., Liu, J., and Shi, J. S., Anti-inflammatory activities of resveratrol in the brain: role of resveratrol in microglial activation. Eur. J. Pharmacol., 636, 1-7 (2010).